Generic Drugmakers Back Ruling Against Tribal Immunity For Patent Reviews

Mealey's (March 12, 2019, 8:48 AM EDT) -- WASHINGTON, D.C. — A case in which a drugmaker is trying to use an Indian tribe’s sovereign immunity to shield it from inter partes review (IPR) of its patents is a...
To view the full article, register now.